Latest filing published 10 Dec 2024 for Pharmala Biotech Holdings Inc..
No signal scores available.
All filings by Harriet de Wit on record concern Pharmala Biotech Holdings Inc. In total, 3 filings cover trades dated from 18 June 2021 to 9 December 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 10 December 2024: an option exercise, in Pharmala Biotech Holdings Inc. Filings reach the SEDI feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations